These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Methods for determining antinuclear antibodies and their clinical significance]. Aeschlimann A; Meyer O; Kahn MF; Müller W Schweiz Med Wochenschr; 1989 Dec; 119(48):1701-12. PubMed ID: 2694362 [TBL] [Abstract][Full Text] [Related]
6. [Simultaneous demonstration of nuclear and mitochondrial antibodies by immunofluorescence]. Sennekamp J; Brunner G; Stroehmann I Dtsch Med Wochenschr; 1973 Jun; 98(24):1223-4. PubMed ID: 4575257 [No Abstract] [Full Text] [Related]
7. [Immunofluorescent studies in some autoimmune syndromes. II. Pemphigus erythematosus]. Chorzelski T; Blaszczyk M Przegl Dermatol; 1971; 58(5):631-5. PubMed ID: 4109788 [No Abstract] [Full Text] [Related]
8. [Antinuclear factors. Demonstration and clinico-diagnostic significance]. Maas D Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549 [No Abstract] [Full Text] [Related]
9. [The value of using HEP/2 cells as compared to sections of rat liver in the detection of autoantibodies using indirect immunofluorescence in human pathology]. Makni S; Jenhani F; Ayed K Rev Rhum Mal Osteoartic; 1989 Oct; 56(10):651-5. PubMed ID: 2512629 [TBL] [Abstract][Full Text] [Related]
11. [Coons' immunomorphologic method in pathology]. Rukosuev VS Arkh Patol; 1969; 31(11):3-13. PubMed ID: 4908415 [No Abstract] [Full Text] [Related]
12. Comparing HEp-2 cell line with rat liver in routine screening test for antinuclear and antinucleolar autoantibodies in autoimmune diseases. Prost AC; Abuaf N; Rouquette-Gally AM; Homberg JC; Combrisson A Ann Biol Clin (Paris); 1987; 45(6):610-7. PubMed ID: 3326434 [TBL] [Abstract][Full Text] [Related]
13. Profile of autoantibodies in human diseases. Burek CL Lab Res Methods Biol Med; 1983; 8():101-20. PubMed ID: 6358739 [TBL] [Abstract][Full Text] [Related]
14. [A study on autoantibodies including anti-nDNA, anti-RNP and anti-Sm antibody in various autoimmune diseases]. Kumagai T; Kameko M; Kanai M; Maruyama K Rinsho Byori; 1985 Mar; 33(3):293-7. PubMed ID: 3874299 [No Abstract] [Full Text] [Related]
15. [Evaluation of indirect immunofluorescence test by Weller and Coons for demonstration of antinuclear factors]. Nebe H Dermatol Monatsschr; 1970 Oct; 156(10):913-8. PubMed ID: 4927926 [No Abstract] [Full Text] [Related]
17. [Evaluation of serologic methods for the determination of antinuclear factors and their differential-diagnostic significance]. Apostoloff E; Apostoloff G; Sönnichsen N; Nebe H Dtsch Gesundheitsw; 1967 Jun; 22(23):1060-5. PubMed ID: 5302966 [No Abstract] [Full Text] [Related]
18. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients]. Nebe H; Blume N Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251 [No Abstract] [Full Text] [Related]
19. [Possibilities of immunofluorescence in clinico-immunologic diagnosis]. Storch W Z Gesamte Inn Med; 1983 Feb; 38(4):104-6. PubMed ID: 6344463 [TBL] [Abstract][Full Text] [Related]
20. [Significance of antinuclear auto-antibodies appearing in the mouse after neo-natal thymectomy]. Thivolet J; Monier JC; Richard MH Pathol Biol; 1967 Dec; 15(23):1155-60. PubMed ID: 4868893 [No Abstract] [Full Text] [Related] [Next] [New Search]